TA
Tiedemann Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $335K | Sell |
661
-4
| -0.6% | -$2.03K | 0.01% | 208 |
|
|
2023
Q2 | $347K | Buy |
665
+4
| +0.6% | +$2.09K | 0.01% | 192 |
|
|
2023
Q1 | $381K | Hold |
661
| – | – | 0.02% | 185 |
|
|
2022
Q4 | $364K | Hold |
661
| – | – | 0.02% | 179 |
|
|
2022
Q3 | $336K | Sell |
661
-7
| -1% | -$3.56K | 0.02% | 176 |
|
|
2022
Q2 | $363K | Sell |
668
-37
| -5% | -$20.1K | 0.03% | 172 |
|
|
2022
Q1 | $416K | Buy |
705
+61
| +9% | +$36K | 0.02% | 203 |
|
|
2021
Q4 | $430K | Sell |
644
-1
| -0.2% | -$668 | 0.02% | 204 |
|
|
2021
Q3 | $369K | Sell |
645
-1,627
| -72% | -$931K | 0.02% | 220 |
|
|
2021
Q2 | $1.15M | Buy |
2,272
+172
| +8% | +$86.8K | 0.05% | 160 |
|
|
2021
Q1 | $961K | Sell |
2,100
-93
| -4% | -$42.6K | 0.04% | 165 |
|
|
2020
Q4 | $1.02M | Buy |
2,193
+48
| +2% | +$22.4K | 0.05% | 149 |
|
|
2020
Q3 | $947K | Sell |
2,145
-284
| -12% | -$125K | 0.05% | 175 |
|
|
2020
Q2 | $880K | Buy |
2,429
+260
| +12% | +$94.2K | 0.05% | 172 |
|
|
2020
Q1 | $616K | Buy |
2,169
+31
| +1% | +$8.8K | 0.04% | 187 |
|
|
2019
Q4 | $697K | Sell |
2,138
-8,209
| -79% | -$2.68M | 0.03% | 189 |
|
|
2019
Q3 | $3.01M | Buy |
10,347
+8,345
| +417% | +$2.43M | 0.14% | 93 |
|
|
2019
Q2 | $588K | Sell |
2,002
-4,439
| -69% | -$1.3M | 0.03% | 188 |
|
|
2019
Q1 | $1.76M | Buy |
6,441
+338
| +6% | +$92.6K | 0.08% | 147 |
|
|
2018
Q4 | $1.37M | Buy |
6,103
+4,567
| +297% | +$1.02M | 0.07% | 165 |
|
|
2018
Q3 | $375K | Buy |
1,536
+18
| +1% | +$4.4K | 0.02% | 242 |
|
|
2018
Q2 | $315K | Buy |
1,518
+247
| +19% | +$51.3K | 0.02% | 253 |
|
|
2018
Q1 | $263K | Buy |
1,271
+170
| +15% | +$35.2K | 0.02% | 236 |
|
|
2017
Q4 | $209K | Hold |
1,101
| – | – | 0.02% | 210 |
|
|
2017
Q3 | $209K | Sell |
1,101
-1,895
| -63% | -$360K | 0.02% | 319 |
|
|
2017
Q2 | $523K | Buy |
+2,996
| New | +$523K | 0.04% | 315 |
|